Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JUAN CARLOS CARDET

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1003071713
CMS profile
317500
Location
TAMPA, FL

General Payments · PY2018–2024

$108,169.38

  • Reported across 146 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$35,112.22

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $31,586.00 9
Food and Beverage $1,551.50 27
Travel and Lodging $1,514.02 2
Grant $460.70 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $65.27 4
PY2019 $272.19 8
PY2020 $2,961.22 6
PY2021 $9,332.50 5
PY2022 $27,493.03 33
PY2023 $32,932.95 51
PY2024 $35,112.22 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $72.13 01/19/2024 Food and Beverage Undisputed 01/23/2026 1105784342 CMS
AstraZeneca Pharmaceuticals LP $113.57 02/25/2024 Food and Beverage Undisputed 01/23/2026 1105900800 CMS
AstraZeneca Pharmaceuticals LP $13.84 02/29/2024 Food and Beverage Undisputed 01/23/2026 1105694622 CMS
AstraZeneca Pharmaceuticals LP $24.82 06/21/2024 Food and Beverage Undisputed 01/23/2026 1104487882 CMS
AstraZeneca Pharmaceuticals LP $1,611.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1105834271 CMS
AstraZeneca Pharmaceuticals LP $29.34 08/10/2024 Food and Beverage Undisputed 01/23/2026 1105788914 CMS
AstraZeneca Pharmaceuticals LP $135.00 10/25/2024 Food and Beverage Undisputed 01/23/2026 1105424829 CMS
AstraZeneca Pharmaceuticals LP $2,148.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1104549156 CMS
Chiesi USA, Inc. $1,130.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1151802657 CMS
Chiesi USA, Inc. $2,260.00 11/29/2024 Consulting Fee Undisputed 01/23/2026 1151802662 CMS
Circassia Inc. $27.82 10/26/2024 Food and Beverage Undisputed 01/23/2026 1082354087 CMS
CSL Behring $13.71 01/17/2024 Food and Beverage Undisputed 01/23/2026 1134637741 CMS
CSL Behring $31.69 02/07/2024 Food and Beverage Undisputed 01/23/2026 1134637743 CMS
Eli Lilly and Company $2,100.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1135110168 CMS
Genentech USA, Inc. $1,200.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1133041818 CMS
Genentech USA, Inc. $25.18 05/10/2024 Food and Beverage Undisputed 01/23/2026 1133041814 CMS
Genentech USA, Inc. $600.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 1133041822 CMS
Genentech, Inc. $24.58 06/06/2024 Food and Beverage Undisputed 01/23/2026 1133041826 CMS
Genentech, Inc. $59.24 10/26/2024 Food and Beverage Undisputed 01/23/2026 1133041831 CMS
GENZYME CORPORATION $15.64 02/22/2024 Food and Beverage Undisputed 01/23/2026 1139837430 CMS
GENZYME CORPORATION $5.31 07/24/2024 Food and Beverage Undisputed 01/23/2026 1139837478 CMS
GENZYME CORPORATION $43.02 08/05/2024 Food and Beverage Undisputed 01/23/2026 1139837486 CMS
GENZYME CORPORATION $9,812.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1139837555 CMS
GENZYME CORPORATION $1.45 10/25/2024 Food and Beverage Undisputed 01/23/2026 1139837518 CMS
GENZYME CORPORATION $91.65 10/25/2024 Food and Beverage Undisputed 01/23/2026 1139837524 CMS
GENZYME CORPORATION $5.79 10/26/2024 Food and Beverage Undisputed 01/23/2026 1139837526 CMS
GlaxoSmithKline, LLC. $9.50 04/26/2024 Food and Beverage Undisputed 01/23/2026 1116171060 CMS
GlaxoSmithKline, LLC. $10,725.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1116591315 CMS
GlaxoSmithKline, LLC. $50.36 09/25/2024 Food and Beverage Undisputed 01/23/2026 1116391560 CMS
GlaxoSmithKline, LLC. $367.54 11/19/2024 Food and Beverage Undisputed 01/23/2026 1116015526 CMS
GlaxoSmithKline, LLC. $515.38 11/19/2024 Travel and Lodging Undisputed 01/23/2026 1116274279 CMS
GlaxoSmithKline, LLC. $998.64 11/19/2024 Travel and Lodging Undisputed 01/23/2026 1116573656 CMS
GlaxoSmithKline, LLC. $460.70 11/19/2024 Grant Undisputed 01/23/2026 1116685923 CMS
Hikma Pharmaceuticals USA $19.22 04/10/2024 Food and Beverage Undisputed 01/23/2026 1127507323 CMS
Lilly USA, LLC $13.35 12/03/2024 Food and Beverage Undisputed 01/23/2026 1135109766 CMS
Novartis Pharmaceuticals Corporation $220.37 04/30/2024 Food and Beverage Undisputed 01/23/2026 1086782387 CMS
Regeneron Healthcare Solutions, Inc. $37.23 01/25/2024 Food and Beverage Undisputed 01/23/2026 1114019033 CMS
Regeneron Pharmaceuticals, Inc. $65.38 05/18/2024 Food and Beverage Undisputed 01/23/2026 1114397198 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.77 03/13/2024 Food and Beverage Undisputed 01/23/2026 1137503130 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.